These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10697685)

  • 1. Evidence for spare beta-adrenoceptors in the rabbit heart.
    Lee JR; Zhang X; Tenner TE
    Proc West Pharmacol Soc; 1999; 42():41-4. PubMed ID: 10697685
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of bromoacetylalprenololmenthane on the responses to isoprenaline of the left ventricle from normo-, prehyper- and hypertensive rats.
    Doggrell SA; Mistry DN; Henderson CJ
    J Auton Pharmacol; 1997 Jun; 17(3):183-90. PubMed ID: 9278778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between desensitization and downregulation of beta-adrenoceptors in cardiac tissues after prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor agonist.
    Sato Y; Kurose H; Nagao T
    Jpn J Pharmacol; 1997 Apr; 73(4):325-32. PubMed ID: 9165369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of alprenolol on the beta-receptor and adenylate cyclase activity in rabbit heart membranes.
    Tkachuk VA; Wollemann M
    Mol Pharmacol; 1981 Jul; 20(1):224-6. PubMed ID: 6270534
    [No Abstract]   [Full Text] [Related]  

  • 5. High efficiency coupling between beta-adrenergic receptors and cardiac contractility: direct evidence for "spare" beta-adrenergic receptors.
    Venter JC
    Mol Pharmacol; 1979 Sep; 16(2):429-40. PubMed ID: 42013
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for an effect of beta-adrenergic stimulation on cardiac performance independent of changes in myocyte calcium handling.
    Berman MR; Peterson JN; Yue DT; Hunter WC
    Prog Clin Biol Res; 1990; 327():751-4. PubMed ID: 2157226
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of bromoacetylalprenololmentane on rat atrial tension development and beta-adrenoreceptors.
    Posner P; Peterson CV; Pitha J; Baker SP
    Eur J Pharmacol; 1984 May; 100(3-4):373-6. PubMed ID: 6329781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic receptors: new concepts and implications for cardiovascular therapeutics.
    Colucci WS; Braunwald E
    Cardiovasc Clin; 1984; 14(3):39-59. PubMed ID: 6144390
    [No Abstract]   [Full Text] [Related]  

  • 9. Permanent effects of postnatal administration of beta-adrenergic ligands on the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA) in rats.
    Izdebska-Straszak G; Gubala E; Jedrzejowska-Szypulka H; Klencki M; Wiczkowski A; Jarzab B
    Neuro Endocrinol Lett; 2006; 27(1-2):105-13. PubMed ID: 16648786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat.
    Bordallo C; Cantabrana B; Velasco L; Secades L; Meana C; Méndez M; Bordallo J; Sánchez M
    Eur J Pharmacol; 2008 Nov; 598(1-3):68-74. PubMed ID: 18755180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors.
    Audigane L; Kerfant BG; El Harchi A; Lorenzen-Schmidt I; Toumaniantz G; Cantereau A; Potreau D; Charpentier F; Noireaud J; Gauthier C
    Exp Physiol; 2009 Apr; 94(4):400-11. PubMed ID: 19151075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulation.
    Brouri F; Findji L; Mediani O; Mougenot N; Hanoun N; Le Naour G; Hamon M; Lechat P
    Eur J Pharmacol; 2002 Dec; 456(1-3):69-75. PubMed ID: 12450571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reserpine-induced supersensitivity and the proliferation of cardiac beta-adrenoceptors.
    Tenner TE; Mukherjee A; Hester RK
    Eur J Pharmacol; 1982 Jan; 77(1):61-5. PubMed ID: 6120846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter.
    Rathi S; Kazerounian S; Banwait K; Schulz S; Waldman SA; Rattan S
    J Pharmacol Exp Ther; 2003 May; 305(2):615-24. PubMed ID: 12606629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of beta 3-adrenoceptors.
    Nisoli E; Carruba MO
    Trends Pharmacol Sci; 1997 Jul; 18(7):257-8. PubMed ID: 9253858
    [No Abstract]   [Full Text] [Related]  

  • 18. Alprenolol and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the beta 1-adrenoceptors of rat left atria.
    Surman AJ; Doggrell SA
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):35-9. PubMed ID: 7678677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac effects of beta-adrenergic receptor antagonists: beta-moderators versus beta-blockers.
    Dhalla NS; Alto LE; Pierce GN; Daly MJ; Dhillon KS; Compier R; Guerin A
    Clin Ther; 1980; 3(4):254-9. PubMed ID: 6115715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic receptor desensitization in cardiac hypertrophy and heart failure.
    Choi DJ; Rockman HA
    Cell Biochem Biophys; 1999; 31(3):321-9. PubMed ID: 10736754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.